person

Luis Gerardo R.

Country
Spain
Department
Hematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 8 partner sites.

Specializations

Hematologic Malignancies

Clinical research activity in hematology spans a broad range of blood cancers, with particular involvement in acute myeloid leukemia, multiple myeloma, and non-Hodgkin lymphoma. The portfolio also includes myelodysplastic syndromes, chronic lymphocytic leukemia, and other relapsed or refractory hematologic conditions.

  • Acute myeloid leukemia
  • Multiple myeloma
  • Non-Hodgkin lymphoma
  • Myelodysplastic syndromes
  • Chronic lymphocytic leukemia

Work in this area reflects interest in treatment-resistant disease, immune-based strategies, and novel approaches for hematologic oncology.

Solid Tumors in Thoracic and Breast Oncology

The investigator is engaged in research across lung cancer and breast cancer, including non-small cell lung cancer, small cell lung cancer, HER2-positive breast cancer, and hormone receptor-positive breast cancer. Additional activity extends to triple-negative breast cancer and advanced metastatic solid tumors.

  • Non-small cell lung cancer
  • Small cell lung cancer
  • HER2-positive breast cancer
  • Hormone receptor-positive breast cancer
  • Triple-negative breast cancer

These studies place emphasis on targeted therapy, biomarker-defined disease, and advanced-stage malignancies.

Genitourinary and Gastrointestinal Cancers

Research involvement also covers prostate cancer, urothelial carcinoma, renal cell carcinoma, and bladder cancer, alongside colorectal cancer, gastric cancer, pancreatic cancer, and hepatocellular carcinoma. The disease mix includes both localized and metastatic gastrointestinal oncology and genitourinary oncology.

  • Prostate cancer
  • Urothelial carcinoma
  • Renal cell carcinoma
  • Colorectal cancer
  • Hepatocellular carcinoma

The therapeutic focus includes disease control in advanced solid tumors and the evaluation of emerging options for difficult-to-treat cancers.

Immune-Mediated and Inflammatory Disorders

Clinical trial activity includes autoimmune disease and inflammatory disorders such as Crohn’s disease, ulcerative colitis, rheumatoid arthritis, systemic lupus erythematosus, and psoriatic arthritis. Additional interest is seen in atopic dermatitis, hidradenitis suppurativa, and primary biliary cholangitis.

  • Crohn’s disease
  • Ulcerative colitis
  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Primary biliary cholangitis

This area also includes conditions linked to immune dysregulation and chronic symptom burden, with a therapeutic emphasis on inflammation control.

Cardiometabolic, Neurologic, and Transplant Medicine

The investigator’s research landscape extends to cardiovascular disease, heart failure, atrial fibrillation, and atherosclerotic cardiovascular disease, as well as kidney disease and renal transplantation. Neurologic involvement includes Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and migraine, with additional work in liver disease and transplant rejection.

  • Heart failure
  • Chronic kidney disease
  • Renal transplantation
  • Alzheimer’s disease
  • Parkinson’s disease

These activities reflect involvement in chronic disease management across internal medicine, neurology, and transplant-related care.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.